Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2022 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

4 results

Results by year

Filters applied: . Clear all
Page 1
Clinical advances in oncolytic virotherapy for pediatric brain tumors.
Ghajar-Rahimi G, Kang KD, Totsch SK, Gary S, Rocco A, Blitz S, Kachurak K, Chambers MR, Li R, Beierle EA, Bag A, Johnston JM, Markert JM, Bernstock JD, Friedman GK. Ghajar-Rahimi G, et al. Among authors: rocco a. Pharmacol Ther. 2022 Nov;239:108193. doi: 10.1016/j.pharmthera.2022.108193. Epub 2022 Apr 26. Pharmacol Ther. 2022. PMID: 35487285 Free PMC article. Review.
Safety and Efficacy of Intraventricular Immunovirotherapy with Oncolytic HSV-1 for CNS Cancers.
Kang KD, Bernstock JD, Totsch SK, Gary SE, Rocco A, Nan L, Li R, Etminan T, Han X, Beierle EA, Eisemann T, Wechsler-Reya RJ, Bae S, Whitley R, Gillespie GY, Markert JM, Friedman GK. Kang KD, et al. Among authors: rocco a. Clin Cancer Res. 2022 Dec 15;28(24):5419-5430. doi: 10.1158/1078-0432.CCR-22-1382. Clin Cancer Res. 2022. PMID: 36239623 Free PMC article.
Combination immunotherapy with vaccine and oncolytic HSV virotherapy is time dependent.
Totsch SK, Ishizuka AS, Kang KD, Gary SE, Rocco A, Fan AE, Zhou L, Valdes PA, Lee S, Li J, Peruzzotti-Jametti L, Blitz S, Garliss CM, Johnston JM, Markert JM, Lynn GM, Bernstock JD, Friedman GK. Totsch SK, et al. Among authors: rocco a. Mol Cancer Ther. 2024 May 6. doi: 10.1158/1535-7163.MCT-23-0873. Online ahead of print. Mol Cancer Ther. 2024. PMID: 38710101